Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Suzuken Co Ltd (9987)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4,649.0 +153.0    +3.40%
01:59:55 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3398000004 
  • Volume: 338,500
  • Bid/Ask: 4,644.0 / 4,657.0
  • Day's Range: 4,536.0 - 4,669.0
Suzuken Co Ltd 4,649.0 +153.0 +3.40%

Suzuken Co Ltd Company Profile

 
Get an in-depth profile of Suzuken Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

13429

Equity Type

ORD

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Pharmaceutical Manufacturing, Pharmacy, and Healthcare-Related Services. The Pharmaceutical Distribution Business segment is involved in the purchase and sale of ethical drugs, pharmaceuticals, diagnostic reagents, and medical equipment and supplies to medical institutions and insurance pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals, and diagnostic reagents focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment is involved in the medication instruction and drug management for in-home patients, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment delivers drugs; provides nursing care services; manufactures, sells, and leases nursing care and medical equipment, such as electrocardiographs, blood pressure monitors, and stethoscopes under Kenz brand name; distributes orphan drugs; develops and operates a product control system for medical materials; sells food products and fixtures and fittings; and develops, manages, and maintains healthcare platforms. This segment also engages in publication and PR activities in the field of medical care and health; and insurance agency business, as well as provides remote image diagnostic support services. In addition, it engages in pharmaceutical logistics business. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.

Contact Information

Address 8 Higashi Kataha-machi Higashi-ku
Nagoya, 461-8701
Japan
Phone 81 52 961 2331
Fax -

Top Executives

Name Age Since Title
Toshimichi Kondo 68 2023 Independent Outside Director
Shunichi Samura 77 2021 Independent Outside Director
Takeshi Ogasawara 70 2021 Independent Outside Director
Shigeru Asano - 2012 President, CEO & Director
Hisashi Tamura - 2016 Director
Hirofumi Tanaka - 2022 Executive MD, Senior GM of Healthcare Distribution Business Headquarters & Director
Chie Takahashi - 2020 SeniorExec. Offr, Sen GM of Healthcaresolutions BusiHeadquarters,GM Solu Busi Plan. Dept & Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

9987 Comments

Write your thoughts about Suzuken Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email